Summit Therapeutics

Yahoo Finance • 5 days ago

Summit Therapeutics Inc. (SMMT) Faces Volatile 2025 as Ivonescimab Gains Approval in China

In this article, we will be taking a look at the 13 Most Oversold Healthcare Stocks So Far in 2025. Summit Therapeutics Inc. stands amongst them. Summit Therapeutics Inc. (NASDAQ:SMMT), a biopharmaceutical company focused on non-small cel... Full story

Yahoo Finance • 7 days ago

Summit Therapeutics Inc. Investigated by the Portnoy Law Firm

LOS ANGELES, Sept. 16, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Summit Therapeutics Inc. investors  ("Summit" or the "Company") (NASDAQ: SMMT) investors that the firm has initiated an investigation into possible securities f... Full story

Yahoo Finance • 12 days ago

QuantumScape rallies as Seeking Alpha analyst pitches the upside

[Financial advisor interacts with a digital interface displaying machine learning data insights.] QuantumScape Corporation (NYSE:QS [https://seekingalpha.com/symbol/QS]) rallied in morning trading on Thursday as it took back ground lost o... Full story

Yahoo Finance • 13 days ago

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Summit Therapeutics Inc. - SMMT

NEW YORK, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Summit Therapeutics Inc. (“Summit” or the “Company”) (NASDAQ: SMMT).  Such investors are advised to contact Danielle Peyton at... Full story

Yahoo Finance • 13 days ago

Rapport Therapeutics prices $250M stock at $26 per share

* Rapport Therapeutics (NASDAQ:RAPP [https://seekingalpha.com/symbol/RAPP]) priced [https://seekingalpha.com/pr/20227241-rapport-announces-pricing-of-public-offering-of-common-stock] an underwritten public offering of 9.62M shares at a p... Full story

Yahoo Finance • 13 days ago

Guggenheim Initiates Summit Therapeutics (SMMT) With a Buy Rating

Summit Therapeutics Inc. (NASDAQ:SMMT) is one of the Best Stocks to Buy for the Next 3 Months According to Hedge Funds. On September 3, Bradley Canino from Guggenheim initiated coverage on Summit Therapeutics Inc. (NASDAQ:SMMT) with a Buy... Full story

Yahoo Finance • 13 days ago

CORRECTION -- Summit Therapeutics Inc. Investigated by the Portnoy Law Firm

LOS ANGELES, Sept. 10, 2025 (GLOBE NEWSWIRE) -- The original press release, distributed Tuesday, September 9, 2025, incorrectly stated that a lawsuit was filed against Summit Therapeutics, in the headline and body of the release. The Por... Full story

Yahoo Finance • 14 days ago

Summit Therapeutics Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. September 24, 2025 Deadline to file Lead Plaintiff Motion.

Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Sept. 09, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Summit Therapeutics Inc. ("Summit" or the "Company") (NASDAQ: SMMT) i... Full story

Yahoo Finance • 14 days ago

S&P Futures Tick Higher Ahead of U.S. Payrolls Revisions

September S&P 500 E-Mini futures (ESU25 [https://www.barchart.com/futures/quotes/ESU25]) are trending up +0.17% this morning, buoyed by hopes for multiple interest rate cuts from the Federal Reserve this year, while investors await an annu... Full story

Yahoo Finance • 15 days ago

Stocks Settle Higher as Bond Yields Fall and Chip Makers Climb

The S&P 500 Index ($SPX) (SPY) on Monday closed up +0.21%, the Dow Jones Industrials Index ($DOWI) (DIA) closed up +0.25%, and the Nasdaq 100 Index ($IUXX) (QQQ) closed up +0.46%.  September E-mini S&P futures (ESU25) rose +0.25%, and Sept... Full story

Yahoo Finance • 15 days ago

Rapport launches proposed public offering of common stock

* Rapport Therapeutics (NASDAQ:RAPP [https://seekingalpha.com/symbol/RAPP]) has commenced an underwritten public offering of $250M of shares of its common stock. * RAPP -5.61% after hours to $29.76. * Source: Press Release [https://s... Full story

Yahoo Finance • 15 days ago

Sector Update: Health Care Stocks Softer Late Afternoon

Health care stocks declined late Monday afternoon, with the NYSE Health Care Index and the Health Ca PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 15 days ago

Stocks making the biggest moves midday: Etsy, EchoStar, Robinhood, Canada Goose & more

Check out the companies making the biggest moves midday: Fortrea — The pharmaceutical trial conductor fell more than 9%. While a catalyst for the move wasn't immediately clear, investors may be booking profits in a recently high-flying nam... Full story

Yahoo Finance • 15 days ago

Stocks Supported by Hopes of Fed Rate Cuts

The S&P 500 Index ($SPX) (SPY) today is up +0.35%, the Dow Jones Industrials Index ($DOWI) (DIA) is up +0.08%, and the Nasdaq 100 Index ($IUXX) (QQQ) is up +0.79%.  September E-mini S&P futures (ESU25) are up +0.35%, and September E-mini N... Full story

Yahoo Finance • 15 days ago

Top Stock Movers Now: EchoStar, Robinhood, T-Mobile, and More

Avishek Das / SOPA Images / LightRocket via Getty Images Shares of EchoStar took off after the DISH TV and Boost Mobile operator sold some spectrum licenses to Elon Musk’s rocket and satellite company SpaceX for about $17 billion Key Take... Full story

Yahoo Finance • 15 days ago

Robinhood & Applovin, SpaceX & EchoStar, Summit Therapeutics

Ramzan Karmali examines some of Monday's trending tickers: Robinhood (HOOD), Applovin (APP), and EMCOR's (EME) joining the S&P 500 (^GSPC), the SpaceX (SPAX.PVT) and EchoStar (SATS) deal, and Summit Therapeutics' (SMMT) stock decline. To... Full story

Yahoo Finance • 15 days ago

Summit Therapeutics Crashes After Failing To Deliver Another Merck-Walloping Punch

Summit Therapeutics stock crashed Monday after the company's drug failed to meet the bar for overall survival in lung cancer. Continue Reading View Comments... Full story

Yahoo Finance • 15 days ago

Top movers in Monday's pre-market session

Before the opening bell on Monday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session. [premarket] TODAY'S PRE-MARKET GAINERS TICKER CHANGE COMMENT HOUR [https://www.ch... Full story

Yahoo Finance • 15 days ago

Summit Therapeutics' Lung Cancer Drug Under Dark Clouds As Keytruda Challenger Shows Regional Data Differences

Summit Therapeutics Inc. (NASDAQ:SMMT), on Sunday, revealed the updated overall survival (OS) results from the global Phase 3 HARMONi trial of ivonescimab at the 2025 World Conference on Lung Cancer (WCLC). The trial included patients wit... Full story

Yahoo Finance • 15 days ago

Stocks making the biggest moves premarket: EchoStar, Robinhood, AppLovin, Alibaba and more

Check out the companies making headlines before the bell. Robinhood , AppLovin — The stock trading app and advertising technology company both surged 8% after S & P Global said the two will join the S & P 500 index , effective before tradi... Full story